National Partners

We work closely with our counterparts nationwide as part of a national consortium of leading academic institutions.

The support of other government agencies is also essential to enabling us to pursue our mission of accelerating research to improve health.

National Institutes of Health

The National Institutes of Health (NIH) is part of the U.S. Department of Health and Human Services, and is the nation's medical research agency—making important discoveries that improve health and save lives. NIH is the largest source of funding for medical research in the world, and supports thousands of scientists in universities and research institutions nationwide and around the globe. It is made up of 27 Institutes and Centers, each with a specific research agenda, often focusing on particular diseases or body systems. Among these is the newly established National Center for Advancing Translational Sciences (NCATS).

As part of the NIH, the National Center for Advancing Translational Sciences (formerly known as the National Center for Research Resources) provides resources, tools, and networks to support more than 30,000 NIH-funded investigators nationwide. Among the programs administered by NCATS is the Clinical and Translational Science Awards (CTSA - See more below). Established in 2006, CTSA includes a national consortium of 60 medical research institutions in 30 states and the District of Columbia that are transforming the way biomedical research is conducted. Its goals are to speed the translation of laboratory discoveries into treatments for patients, to engage communities in clinical research efforts, and to train a new generation of clinical and translational researchers. Also see, CTSA Center for Leading Innovation and Collaboration (CLIC) website.

In 2016, we received a five-year renewal grant of $85 million to continue our work in support of clinical and translational science. Learn more

Clinical & Translational Science Award Consortium

Working together as a national consortium, the 62 Clinical & Translational Science Awards (CTSA) institutions share a common vision to improve human health by transforming the research and training environment to enhance the efficiency and quality of clinical and translational research. The CTSA program is led by the National Center for Research Resources, part of the National Institutes of Health. View a list of all CTSA institutions.

Note: CTSI Consultation Services provides expert advice to investigators with the goal of improving the quality and quantity of science at UCSF and affiliated institutions. Easily accessible, comprehensive and integrated consultations are available in diverse research fields at every stage of a study.

Trial Innovation Network (TIN)

The Trial Innovation Network is a collaborative initiative within the CTSA Program and is composed of three key partners – the CTSA Program Hubs, the Trial Innovation Centers (TICs), and the Recruitment Innovation Center (RIC).

The vision for the Trial Innovation Network is to innovatively address critical roadblocks in clinical research and accelerate the translation of novel interventions into life-saving therapies. The Trial Innovation Network is a collaborative national network that focuses on operational innovationoperational excellence and collaboration and will leverage the expertise and resources of the CTSA Program. The Trial Innovation Network will feature a single IRB system, master contracting agreements, quality by design approaches, and a focus on evidence-based strategies to recruitment and patient engagement.

The goal of the Trial Innovation Network is to not only execute trials better, faster, and more cost-efficiently but, importantly, to be a national laboratory to study, understand and innovate the process of conducting clinical trials. UC San Francisco is a Liaison to the Recruitment Innovation Center. Learn more

Patient-Centered Outcomes Research Institute (PCORI)

PCORI funds research that offers patients and caregivers the information they need to make important healthcare decisions. Its scientific research portfolio is divided among two programs, which together reflect its National Priorities for Research. Each program leads the development of PCORI Funding Announcements that may be either broad calls for applications or targeted to specific topics. These programs also participate in the selection of awards and oversee the projects as they progress.

In addition, the Evaluation and Analysis program provides evaluation expertise, while the Engagement program gives patients, caregivers, clinicians, and other healthcare stakeholders opportunities for meaningful involvement in all our activities.